Viewing Study NCT00622869


Ignite Creation Date: 2025-12-24 @ 10:51 PM
Ignite Modification Date: 2026-02-22 @ 7:03 PM
Study NCT ID: NCT00622869
Status: COMPLETED
Last Update Posted: 2013-05-27
First Post: 2008-02-13
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Efficacy and Safety of Concentration-controlled Everolimus to Eliminate or to Reduce Tacrolimus Compared to Tacrolimus in de Novo Liver Transplant Recipients
Sponsor: Novartis Pharmaceuticals
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Liver Transplantation View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Liver transplantation View
None everolimus View
None calcineurin inhibitors View
None tacrolimus View
None renal function View
None MDRD formula View
None progression of fibrosis View